Vaccine Manufacture and Supply – News and Features

A new study has shown that a single dose of the HPV vaccine has the same efficacy as the current three-dose regimen.

This article will explore how the optimization of cell culture growth medium, the development of superior biological models and the reduced reliance on animal-derived components continue to drive vaccine development.

Researchers are rolling out a data set that provides detailed information on COVID-19 vaccine shipments and wastage across the United States, with the goal of spurring new data analysis to improve vaccination efforts in the future.

A survey has been conducted to uncover how the public feels about the distribution of vaccines.

A universal flu vaccine to cover all emerging strains is being pursued. Anthony King explores the current research landscape.

A study has reviewed dozens of evaluations of four COVID-19 vaccines and found that they retain nearly all of their ability to prevent severe disease up to six months after full vaccination.

An inhaled vaccine for SARS-CoV-2 has been shown to provide broad immunity against the virus and is currently in a phase one clinical trial.

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study takes a promising step in the direction of developing an HIV vaccine.

Scientists at The Wistar Institute have developed a more targeted COVID-19 vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.

Researchers have proven that COVID-19 vaccines can be kept ultra-cool for an extended period, providing a resource for safe delivery to remote locations.